139 related articles for article (PubMed ID: 12881376)
1. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.
Duffy SW; Tabar L; Vitak B; Yen MF; Warwick J; Smith RA; Chen HH
Ann Oncol; 2003 Aug; 14(8):1196-8. PubMed ID: 12881376
[TBL] [Abstract][Full Text] [Related]
2. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
[TBL] [Abstract][Full Text] [Related]
3. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
[TBL] [Abstract][Full Text] [Related]
4. Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results.
Tabar L; Vitak B; Chen HH; Prevost TC; Duffy SW
Swiss Surg; 1999; 5(5):199-204. PubMed ID: 10546517
[TBL] [Abstract][Full Text] [Related]
5. Mammographic screening: evidence from randomised controlled trials.
de Koning HJ
Ann Oncol; 2003 Aug; 14(8):1185-9. PubMed ID: 12881373
[TBL] [Abstract][Full Text] [Related]
6. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.
Yen AM; Duffy SW; Chen TH; Chen LS; Chiu SY; Fann JC; Wu WY; Su CW; Smith RA; Tabár L
Cancer; 2012 Dec; 118(23):5728-32. PubMed ID: 22605639
[TBL] [Abstract][Full Text] [Related]
7. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
Tabár L; Vitak B; Chen TH; Yen AM; Cohen A; Tot T; Chiu SY; Chen SL; Fann JC; Rosell J; Fohlin H; Smith RA; Duffy SW
Radiology; 2011 Sep; 260(3):658-63. PubMed ID: 21712474
[TBL] [Abstract][Full Text] [Related]
8. The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease.
Duffy SW; Tabar L; Vitak B; Day NE; Smith RA; Chen HH; Yen MF
Eur J Cancer; 2003 Aug; 39(12):1755-60. PubMed ID: 12888371
[TBL] [Abstract][Full Text] [Related]
9. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
10. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
[TBL] [Abstract][Full Text] [Related]
11. Some random-effects models for the analysis of matched-cluster randomised trials: application to the Swedish two-county trial of breast-cancer screening.
Nixon R; Prevost TC; Duffy SW; Tabar L; Vitak B; Chen HH
J Epidemiol Biostat; 2000; 5(6):349-58. PubMed ID: 11234739
[TBL] [Abstract][Full Text] [Related]
12. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
13. Computer modelling of the Swedish two county trial of mammographic screening and trade offs between participation and screening interval.
Fett MJ
J Med Screen; 2001; 8(1):39-45. PubMed ID: 11373849
[TBL] [Abstract][Full Text] [Related]
14. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.
Tabar L; Fagerberg G; Duffy SW; Day NE
J Epidemiol Community Health; 1989 Jun; 43(2):107-14. PubMed ID: 2512366
[TBL] [Abstract][Full Text] [Related]
15. Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening.
Tabár L; Chen HH; Fagerberg G; Duffy SW; Smith TC
J Natl Cancer Inst Monogr; 1997; (22):43-7. PubMed ID: 9709274
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE
Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907
[TBL] [Abstract][Full Text] [Related]
17. [Norwegian breast cancer mortality rates and validity of Swedish mammographic studies].
Zahl PH; Kopjar B; Maehlen J
Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1928-31. PubMed ID: 11488185
[TBL] [Abstract][Full Text] [Related]
18. An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts.
Nystrom L; Larsson LG; Wall S; Rutqvist LE; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabar L
J Med Screen; 1996; 3(2):85-7. PubMed ID: 8849766
[TBL] [Abstract][Full Text] [Related]
19. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer screening with mammography: overview of Swedish randomised trials.
Nyström L; Rutqvist LE; Wall S; Lindgren A; Lindqvist M; Rydén S; Andersson I; Bjurstam N; Fagerberg G; Frisell J
Lancet; 1993 Apr; 341(8851):973-8. PubMed ID: 8096941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
